• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Tapeworm's trick could make drugs more effective

April 1, 2003

Madison, Wis. ­To survive and thrive in a decidedly hostile environment, the lowly tapeworm uses a chemical trick to evade the propulsive nature of its intestinal home, say scientists at the University of Wisconsin-Madison (UW).

Madison, Wis. ­

To survive and thrive in a decidedly hostile environment, the lowly tapeworm uses a chemical trick to evade the propulsive nature of its intestinal home, say scientists at the University of Wisconsin-Madison (UW).

Capitalizing on that tapeworm chemistry, scientists at UW believe theymay have found a way to slow the transit of drugs through the intestine,making them more effective in their delivery and holding out the promisenot only of more effective treatment, but also of lowering dosage and cost,and eliminating wasted medicine.

This new insight comes via the tapeworm Hymenolepis diminuta, a speciesfound in rats and long used as a research model by parasitologists. By sortingthrough the soup of biochemicals the tapeworm uses to influence muscle activityin the gut, a group led by John Oaks of the School of Veterinary Medicine,and Paul Bass of the School of Pharmacy, has isolated a chemical signalfactor that may help prolong the time it takes for medicines to move throughthe small intestine.

"Most oral medications would benefit from prolonged small intestinalresidence," says Bass, an emeritus professor of pharmacy. "Almostall drugs we take orally are absorbed from the small intestine. By prolongingthe medication's residence time in that organ, we should enhance its absorptionand obtain higher blood levels of the medication."

The compound characterized by Oaks and Bass, known in scientific shorthandas cyclic GMP, is a member of a family of compounds known generically assignal factors. Its role is to alter the electrochemical activity of themuscles in the intestine, slowing or shutting down intestinal transit ofthe host, actions that help the tapeworm obtain a meal or otherwise survivein an organ designed to quickly sweep food along.

"Inside cells, cyclic GMP is a signal molecule," notes Oaks,a professor of comparative bioscience. "It tells cells how to behave.When the tapeworm secretes this signal molecule, the intestine closes offand nothing moves. That suggested to us that the intestine is not digestingmaterial as it normally would."

Advertisement

The cyclic GMP compound, Oaks adds, is cheap and easy to synthesize.Its use as an additive to medicines has been patented by the Wisconsin AlumniResearch Foundation.

"Many drugs are absorbed at less than 50 percent from the intestine,"says Oaks. "The key will be can we use cyclic GMP with certain kindsof drugs to increase their level of uptake into the blood?"

Other potential benefits associated with lower dosages include lessenedside effects and fewer chemicals released into the environment. A recentsurvey of surface water in the United States revealed a growing presenceof drugs in the environment. The suspected sources are medicines that arenot completely metabolized by the humans and animals they are administeredto.

"If we could halve the dosage, we could lower the percentage ofnonabsorbed drug that ends up in the environment," says Oaks.

The work done by the Wisconsin team, which also included K. Dubear Kroeningand Noah P. Zimmerman, was funded in part by a grant from the National Institutesof Health.


Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement